Chinese english Germany Japanese Korea

Lipid 8

Lipid 8 Struktur
2226547-25-5
CAS-Nr.
2226547-25-5
Englisch Name:
Lipid 8
Synonyma:
Lipid 8;2-(Di((9Z,12Z)-octadeca-9,12-dien-1-yl)amino)ethyl 4-(dimethylamino)butanoate;Butanoic acid, 4-(dimethylamino)-, 2-[di-(9Z,12Z)-9,12-octadecadien-1-ylamino]ethyl ester
CBNumber:
CB010659078
Summenformel:
C44H82N2O2
Molgewicht:
671.15
MOL-Datei:
2226547-25-5.mol
Request For Quotation

Lipid 8 Eigenschaften

Siedepunkt:
690.3±55.0 °C(Predicted)
Dichte
0.898±0.06 g/cm3(Predicted)
pka
9.37±0.28(Predicted)
Aggregatzustand
Liquid
Farbe
Colorless to light yellow

Sicherheit

Lipid 8 Chemische Eigenschaften,Einsatz,Produktion Methoden

Lipid 8 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Lipid 8 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 13)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai UCHEM Inc. 		+862156762820 +86-13564624040
 sales@myuchem.com China 7190 58
Tianjin Kailiqi Biotechnology Co., Ltd. 15076683720
 klq@cw-bio.com China 4198 55
DC Chemicals 021-58447131 13564518121
 sales@dcchemicals.com China 9412 58
Wuxi Donghe Pharmaceutical Technology Co., Ltd. 63313187 15358055255
 63313187@qq.com China 1993 58
Bide Pharmatech Ltd. 400-1647117 13681763483
 product02@bidepharm.com China 62163 58
Shanghai Maclean Biochemical Technology Co., LTD 021-50706066 15221275939
 shenlinxing@macklin.cn China 29802 58
Dream Chemical (Tianjin) Co., Ltd 16600677255 18522952724
 public@dreamchem.cn China 859 58
Shanghai Easy CDMO Co.,Ltd 021-61734564
August@easycdmo.com China 10010 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627
 customer_service@efebio.com China 11975 58
Tianjin Ruide Famo Technology Co., Ltd 13821803402
 RD_PHARM@163.com China 842 58
  • Lipid 8
  • Butanoic acid, 4-(dimethylamino)-, 2-[di-(9Z,12Z)-9,12-octadecadien-1-ylamino]ethyl ester
  • 2-(Di((9Z,12Z)-octadeca-9,12-dien-1-yl)amino)ethyl 4-(dimethylamino)butanoate
  • 2226547-25-5
Copyright 2019 © ChemicalBook. All rights reserved